Accéder au contenu
Merck
Toutes les photos(1)

Principaux documents

Voir toute la documentation

40263-U

Supelco

Diphenylamine solution

certified reference material, 5000 μg/mL in methanol

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(1)

About This Item

Numéro CAS:
122-39-4
Code UNSPSC :
77101502
Nomenclature NACRES :
NA.24

Qualité

certified reference material
TraceCERT®

Niveau de qualité

300

Gamme de produits

TraceCERT®

CofA (certificat d'analyse)

current certificate can be downloaded

Conditionnement

ampule of 1 mL

Concentration

5000 μg/mL in methanol

Technique(s)

HPLC: suitable
gas chromatography (GC): suitable

Application(s)

environmental

Format

single component solution

Température de stockage

2-8°C

InChI

1S/C12H11N/c1-3-7-11(8-4-1)13-12-9-5-2-6-10-12/h1-10,13H

Clé InChI

DMBHHRLKUKUOEG-UHFFFAOYSA-N

Application

Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.

Autres remarques

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

Informations légales

TraceCERT is a registered trademark of Merck KGaA, Darmstadt, Germany

Pictogrammes

FlameSkull and crossbonesHealth hazard
GHS02,GHS06,GHS08

Mention d'avertissement

Danger

Classification des risques

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Aquatic Chronic 3 - Flam. Liq. 2 - STOT SE 1

Organes cibles

Eyes,Central nervous system

Code de la classe de stockage

3 - Flammable liquids

Classe de danger pour l'eau (WGK)

WGK 2

Point d'éclair (°F)

51.8 °F - closed cup

Point d'éclair (°C)

11 °C - closed cup

Équipement de protection individuelle

Eyeshields, Faceshields, Gloves

Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number
LRAD3429
LRAD0324
LRAC6818
LRAB9228
XA13814V

Vous ne trouvez pas la bonne version ?

Si vous avez besoin d'une version particulière, vous pouvez rechercher un certificat spécifique par le numéro de lot.

Rechercher un(e) COA

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Les clients ont également consulté

Slide 1 of 5

1 of 5

Acide sulfurique for the determination of nitrogen, ≥97.0%

Supelco

84727

Acide sulfurique

N-Nitrosodimethylamine solution certified reference material, 5000 μg/mL in methanol, ampule of 1 mL

Supelco

CRM40059

N-Nitrosodimethylamine solution

Pyridine ACS reagent, ≥99.0%

Sigma-Aldrich

360570

Pyridine

Acide sulfurique 99.999%

Sigma-Aldrich

339741

Acide sulfurique

Acide sulfurique ACS reagent, 95.0-98.0%

Sigma-Aldrich

258105

Acide sulfurique

Jonathan N King et al.
American journal of veterinary research, 74(3), 465-472 (2013-02-27)
To establish pharmacokinetics of robenacoxib after administration to cats via the IV, SC, and oral routes. 24 cats. In a crossover design, robenacoxib was administered IV, SC, and orally (experiment 1) and orally (experiment 2) to cats with different feeding
David Bennett et al.
BMC veterinary research, 9, 42-42 (2013-03-05)
Robenacoxib is a novel and highly selective inhibitor of COX-2 in dogs and cats and because of its acidic nature is regarded as being tissue-selective. Thirty four dogs with stifle osteoarthritis secondary to failure of the cranial cruciate ligament were
Kellie Hom et al.
Journal of medicinal chemistry, 56(5), 2097-2109 (2013-02-06)
Bacteria require iron for survival and virulence and employ several mechanisms including utilization of the host heme containing proteins. The final step in releasing iron is the oxidative cleavage of heme by HemO. A recent computer aided drug design (CADD)
John G Albeck et al.
Molecular cell, 49(2), 249-261 (2012-12-12)
The EGF-stimulated ERK/MAPK pathway is a key conduit for cellular proliferation signals and a therapeutic target in many cancers. Here, we characterize two central quantitative aspects of this pathway: the mechanism by which signal strength is encoded and the response
Vince R Torti et al.
Molecular cancer therapeutics, 11(10), 2274-2283 (2012-07-04)
Clinical trials of selective RAF inhibitors in patients with melanoma tumors harboring activated BRAFV600E have produced very promising results, and a RAF inhibitor has been approved for treatment of advanced melanoma. However, about a third of patients developed resectable skin
Afficher tous les articles scientifiques apparentés

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique